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Abstract  
We are presenting a rare case of bilateral breast cancer. A 65-year-old female reported to us with complaint of lump in the 
left breast. There was positive family history. The patient was diagnosed with carcinoma breast of left side on edge biopsy and of 
right side by ultrasonography, which was confirmed on fine needle aspiration cytology. At the time of admission, ultrasonography of 
the abdomen and right breast were normal. After 1 month, the patient was readmitted with redness over the inner quadrant of the 
right breast skin.  
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Introduction 
A second primary breast cancer in the opposite 
breast can be either synchronous or metachronous. The 
majority are metachronous [1]. Bilateral synchronous 
breast cancer accounts for 0.2-2% of all breast cancers 
[2]. Synchronous bilateral breast carcinoma (SBBC) is an 
uncommon presentation, and the management of patients 
with this disease is not well established [3]. Breast cancer 
is usually associated with local and lymphatic spread and 
with blood-borne spread to lungs, bones and liver. Our 
patient’s bilateral breast carcinoma (BBC) was consistent 
with this definition of being SBBC. 
Case report – A 65 year-old woman came to our 
Breast unit due to a palpable lesion in her left breast. 
From the personal history, the woman had risk factors of 
positive family history for breast cancer. Her mother was 
diagnosed with breast cancer of right side. There were no 
other complaints like weight loss, fever or loss of appetite. 
Clinical examination of the left breast revealed a 
hard lump in the upper quadrant of size 14 x 10 cm that 
was fixed to the underlying structures. The overlying skin 
of the breast along with nipple and areola were involved. 
Multiple lymph nodes were felt in the axilla, out of which 
one was large in size - of about 2x3cm, which was mobile.   
On right side of breast, skin was reddish in 
colour in lower and inner quadrant but no lump was felt 
(Figure 1). Nipple was inverted. No axillary lymph nodes 
were felt. Routine blood tests were within normal limits 
including chest X-ray. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1 Gross picture showing operated site on left breast 
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In ultrasound of the left breast, the consistency 
of the lesion was solid and multilobular. Additionally, 
ultrasonography of the right breast demonstrated a non-
palpable lesion, consisting of clustered micro 
calcifications of a diameter equal to 0.7 cm in the upper 
outer quadrant. Abdominal ultrasonography revealed no 
metastasis. Fine needle aspiration cytology confirmed the 
malignancy of both breasts. On the right side, it came as 
invasive lobular carcinoma and on the left side, it came as 
ductal carcinoma. Modified radical mastectomy with 
axillary clearance and skin grafting was performed on the 
left breast. Pathological specimen showed a large well-
demarcated tumour mass measuring 14 x 10 x 9 cm, firm 
to hard in consistency. Histopathological examination 
confirmed the diagnose of ductal carcinoma with lymph 
node infiltration. Specimen revealed 9 lymph nodes.  
Post-operatively, the patient was on adjuvant 
chemotherapy and responded very well to the treatment.  
Discussion  
Synchronous tumours are defined as two or 
more tumours where each are malignant, are distinct from 
each other i.e. of different histological type and where 
neither can originate with metastasis from another tumor 
[4]. The incidence of synchronous bilateral cancer is of 
approximately 1% to 2% and that of metachronous cancer 
5% to 6%.Bilateral synchronous breast cancer is an 
uncommon finding in women presenting with multiple 
breast lumps. It is reported to account for approximately 
1% to 2% of women with breast cancer whereas 
metachronous breast tumours account for 5% to 6 % of 
cancer cases [5]. The cancer can be invasive or 
noninvasive [1]. The incidence pattern of synchronous 
cancer is similar to that  of unilateral disease, although 
without any notable trends in recent decades [6]. Although 
its aetiology is not well understood, however it appears 
that this familial link is more likely with metachronous 
bilateral breast cancer than either unilateral or 
synchronous bilateral cases. Furthermore, the risk of 
having breast cancer is substantially increased with a 
first-degree relative with bilateral breast cancer [7]. 
Such lower disease free survival and high rates of distant 
metastasis is a recognized feature of bilateral 
synchronous tumors, which therefore have a worse 
overall survival compared to unilateral tumours [5]. 
However, there does not appear to be any difference in 
survival if synchronous tumours are compared to the 
metachronous ones. The gradual increase in the 
incidence of synchronous disease  during the 1970s 
coincides with the introduction of routine  and bilateral 
mammography as part of the diagnostic work-up  in 
women with unilateral cancer [6]. Bilateral cancers are 
detected early by preclinical work-up, and classified  as 
synchronous disease rather than diagnosed later as 
metachronous disease [6]. Synchronous breast cancer 
has a poorer prognosis than metachronous or unilateral 
breast cancer [8]. Nowadays, the incidence of local 
recurrences, bilateral cancer, and distant metastasis are 
reduced with the use of adjuvant systemic therapy, mainly 
tamoxifen and chemotherapy that became clinical practice 
[9].  
Conclusion  
The incidence of invasive cancer detected by 
random biopsy of the opposite breast is not high enough 
to justify routine adoption of this procedure. The 
remaining breast must be followed for the remainder of 
the patient life by physical examination and annual 
mammography. The treatment of the secondary primary 
breast cancer should be that appropriate for the stage of 
the disease. The prognosis for the woman with a second 
primary breast cancer is quite favorable and is dependent 
on the stage of both the first and the second cancer. 
Source of funds and conflict of interest is nil. 
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